Translation and Impact of Funded Australian Cardiovascular Research: A Review With Perspective

Heart Lung Circ. 2021 Oct;30(10):1442-1448. doi: 10.1016/j.hlc.2021.04.025. Epub 2021 Jun 3.


This aim of this paper is to set the scene for the need for impact assessment and return on investment in funded cardiovascular research in Australia, starting with the historical perspective on waste in health and medical research. Recently there has been a substantial move from discussion and policy about the need for research translation, into practice and application via the evolution of funding streams like the Australian Medical Research Future Fund (MRFF). Health and medical research funders play a critical role in both setting the expectations for research translation and impact and helping researchers to meet these expectations. As a leading cause of death, cardiovascular disease is a national health priority, recognised as such with a AUD$220 million MRFF allocation to the Cardiovascular Health Mission. Focussing on cardiovascular research, we address some of the barriers researchers face in prospectively planning for research translation and impact assessment, and call for an ecosystem that supports a return on investment for all stakeholders, especially the community and patient end-users.

Keywords: Cardiovascular; Economic; Funding; Health; Impact assessment; Medicine; Research; Return on investment; Translation; Value.

Publication types

  • Review

MeSH terms

  • Australia / epidemiology
  • Biomedical Research*
  • Ecosystem
  • Financial Management*
  • Humans
  • Research Personnel